← Leaderboards
Haiyang Yu
Ludwig Institute For Cancer Res Ltd
$614,630
Attributed
$614,630
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2018–22$250K$187.5K$125K$62.5K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$614,630 · 3
By mechanism
K99$249,588 · 1
R00$249,000 · 1
F32$116,042 · 1
Top collaborators
No co-investigators on record.
Most similar at Ludwig Institute For Cancer Res Ltd
Same institution · by research overlap
- Shuying Sun$11,240,869
- Jie Jiang$2,738,745
- Sandrine Da Cruz$1,083,890
- Magdalini Polymenidou$300,242
Others in their field
Other Emerging Leaders on “Proteins”
- John Damon Chodera · Sloan-Kettering Inst Can Research$50,971,767
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$40,723,314
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
Research focus
ProteinsNerve DegenerationMouse ModelPathologyTransgenic MiceCell LineMediatingMotor NeuronsNeuraxisPathologicS DiseaseSerineProtein Tdp-43NeuronsFrontotemporal Lobar Dementia-Amyotrophic Lateral SclerosisGenesAlzheimer&AposBrainAmyotrophic Lateral SclerosisAuthorshipConsensusCryoelectron MicroscopyAntisense OligonucleotidesCell Nucleus
Grant awards (5)
Determining the molecular organization of TDP-43 in liquid spherical annuli and establishing a designer gene therapeutic strategy to degrade TDP-43 aggregates$249,000
R00 · FY2022 · NS · contact PI
Determining the molecular organization of TDP-43 in liquid spherical annuli and establishing a designer gene therapeutic strategy to degrade TDP-43 aggregates$124,794
K99 · FY2021 · NS · contact PI
Determining the molecular organization of TDP-43 in liquid spherical annuli and establishing a designer gene therapeutic strategy to degrade TDP-43 aggregates$124,794
K99 · FY2020 · NS · contact PI
Determine how loss-of-function of the TBK1 kinase causes age-dependent degeneration in frontotemporal dementia$53,559
F32 · FY2019 · AG · contact PI
Determine how loss-of-function of the TBK1 kinase causes age-dependent degeneration in frontotemporal dementia$62,483
F32 · FY2018 · AG · contact PI